34th International Symposium on ALS/MND

“Congratulations on another very successful meeting, the virtual symposium required so many new approaches to overcome truly unexpected challenges.  I am continually amazed how each year the MND Association always rises to the occasion and does so with such grace. Cytokinetics is so proud to join alongside you to support this meeting as it ranks amongst our very top priorities each year.  We feel so at home with you and this annual meeting continually serves to reinforce why we do what we do.” 

“[MND research has] gone from a cloud of uncertainty to a sort of roadmap for how we might treat and cure motor neurone disease… I think that’s happened in relatively recent years and you can see that from the meeting. The attendance numbers have gone up and more engagement from the pharmaceutical industry means we have made tremendous progress. I think the International Symposium is really part of the process, it’s the way people come together, and it’s recognised as the premier meeting in the field each year. I’ve been very grateful to be part of that.”

“For me, living in an ALS body that’s increasingly isolated, I start or tend to think of my experience as somehow mine alone. The greatest personal benefit of the Symposium was to remind me of the breadth of research and global nature of what I’m experiencing personally.”